Search Icon
Home
Resources
Blog

Blog

  • Blog

Pharmacy Benefit Managers Are Blocking Patient Access to Biosimilar Insulin
  • Blog

U.S. Patients Rely On Generic Medicines But Increases In Drug Shortages Reflect Challenges To Their Long-Term Sustainability
  • Blog

Associate Members Spotlight: Antheia
  • Blog

Shamekka Shares Why We Should Never Take Moms #4GRxANTED
  • Blog

A Look Back at Access! 2023
  • Blog

The Quickest Route to U.S. Essential Medicines Production: Existing and Idle Production Sites
  • Blog

Desi is Back Playing Soccer and Doing “Normal Kid” Stuff
  • Blog

Generics and Biosimilars Offer Savings for Patients Fighting Cancer, Heart Disease and Other Conditions
  • Blog

Ensuring Patient Access to Amoxicillin When Demand is High
  • Blog

Back Together: GRx+Biosims 2022 Conference Recap
  • Blog

Patients Pay More When Generic Drugs Are Placed On Non-Generic Tiers, Even Though Prices For Generics Are Going Down
  • Blog

Member Spotlight: Meitheal Pharmaceuticals
Load More
Association for Accessible Medicines
601 New Jersey Ave NW, Suite 850
Washington DC 20001
JOIN

Advocacy

About Us

Events

Resources

Sign-up for Update

Receive relevant industry news, event information and the latest resources on biosimilars and generic medicines.

Subscribe
© 2025 Association for Accessible Medicines (AAM), All Rights Reserved Privacy Policy  |  Terms of Use  |  Contact

Stay Connected

For the latest updates, follow us on social media.

Facebook-f X-twitter Linkedin-in Youtube Instagram